Erythropoietin and Early Iron Supplement and Retinopathy of Prematurity
Status:
Unknown status
Trial end date:
2006-12-01
Target enrollment:
Participant gender:
Summary
To evaluate the possibility that erythropoietin with early iron supplementation may induce
retinopathy of prematurity or worsen this disease. In addition risk factors for the
development of ROP will be checked.